Drug Interaction Report

Darifenacin and Buprenorphine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Darifenacin

Enablex
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 23 documented Darifenacin interactions, 22 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Taking buprenorphine with darifenacin can add up to cause severe constipation or trouble urinating, so watch for those signs and report them to your care team, who can adjust and monitor as needed.

You've been prescribed buprenorphine (a strong pain or opioid-dependence medicine) along with darifenacin (Enablex, used for an overactive bladder). Both of these can slow down your gut and make it harder to empty your bladder. When taken together, those effects can add up.

In rare cases, this could lead to severe constipation or trouble urinating, and very rarely the bowel can nearly stop moving (called a paralytic ileus). This is a theoretical concern, not something that happens to everyone. The good news is your care team can manage it easily by keeping an eye on you and adjusting things if needed. Call them if you notice belly pain, bloating, no bowel movements, or trouble peeing.

Effect: Additive risk of severe constipation, urinary retention, and potentially paralytic ileus with concomitant buprenorphine (opioid) and darifenacin (M3-selective anticholinergic).

Mechanism: Pharmacodynamic additive suppression of GI motility and detrusor tone. Opioid-induced constipation plus antimuscarinic reduction of gut motility and bladder emptying.

  • Direction: Increased anticholinergic/constipating burden (neither is a prodrug; effect is PD, not PK).
  • Severity: Major. Evidence: Theoretical. Onset: Unspecified.
  • Management: Monitor for reduced bowel motility, abdominal distension, and urinary retention. Encourage bowel regimen/hydration; dose individualized by the care team.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of paralytic ileus

Interaction Deep Dive

When buprenorphine is given together with an anticholinergic agent, the combination may lead to urinary retention or to severe constipation that can progress to paralytic ileus. In patients receiving buprenorphine alongside anticholinergic drugs, watch for indications of urinary retention or diminished gastric motility1.

Why it happens (mechanism)

Additive effects on gastric motility

How to manage this interaction

Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Because both can slow the gut and bladder, your care team's main job here is to watch you a bit more closely.

  • Your team may monitor you more closely for constipation or trouble urinating, and doses can be adjusted and individualized if needed.
  • Staying hydrated and staying active can help keep things moving.
  • Tell your pharmacist or doctor promptly about severe constipation, bloating, belly pain, no bowel movements, or difficulty passing urine.

Ask your pharmacist whether a stool softener or laxative is appropriate for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Darifenacin and Buprenorphine together?

Taking buprenorphine with darifenacin can add up to cause severe constipation or trouble urinating, so watch for those signs and report them to your care team, who can adjust and monitor as needed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Darifenacin and Buprenorphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Darifenacin and Buprenorphine interaction managed?

Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Because both can slow the gut and bladder, your care team's main job here is to watch you a bit more closely. Your team may monitor you more closely for constipation or trouble urinating, and doses can be adjusted and individualized if needed. Staying hydrated and staying active can help keep things moving… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Darifenacin or Buprenorphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.